TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Cand Pharm C. Cristoffersen AS
Closing information (x1000 EUR)
| Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Turnover |
18,363
|
16,641
|
15,760 |
| Financial expenses |
24
|
24
|
29 |
| Earnings before taxes |
1,052
|
1,139
|
707 |
| Total assets |
8,397
|
7,162
|
6,764 |
| Current assets |
6,543
|
5,449
|
4,785 |
| Current liabilities |
2,669
|
2,181
|
2,345 |
| Equity capital |
5,728
|
4,980
|
4,315 |
| - share capital |
253
|
249
|
254 |
| Employees (average) | 49 | ||
| Shareholders | 0 | 0 | 0 |
Financial ratios
| Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Solvency |
68.2%
|
69.5%
|
63.8% |
| Turnover per employee | 322 | ||
| Profit as a percentage of turnover |
5.7%
|
6.8%
|
4.5% |
| Return on assets (ROA) |
12.8%
|
16.2%
|
10.9% |
| Current ratio |
245.1%
|
249.8%
|
204.1% |
| Return on equity (ROE) |
18.4%
|
22.9%
|
16.4% |
| Change turnover |
1,440
|
1,178
|
1,381 |
| Change turnover % |
9%
|
8%
|
10% |
| Chg. No. of employees | 3 | ||
| Chg. No. of employees % | 7% |
Total value of public sale
| Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.